Syndax Pharmaceuticals Reports Fourth Quarter and Year-end 2016 Financial Results and Provides Clinical and Business Update

Go back to Syndax Pharmaceuticals Reports Fourth Quarter and Year-end 2016 Financial Results and Provides Clinical and Business Update
(NASDAQ: SNDX) Delayed: 19.61 +0.29 (1.50%)
Previous Close $19.32    52 Week High $18.03 
Open $19.32    52 Week Low $8.97 
Day High $20.00    P/E N/A 
Day Low $19.21    EPS $0.00 
Volume 1,014,609